Target intelligence / Profile preview

Gamma-aminobutyric acid receptor subunit beta-2 (GABRB2) (GABRB2)

Target
GABRB2
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Cys-loop receptor family
01

Overview

The Gamma-aminobutyric acid receptor subunit beta-2 (GABRB2) is a fundamental component of the GABA_A receptor, the primary inhibitory neurotransmitter receptor in the mammalian brain (UniProt: P47870). As a member of the Cys-loop ligand-gated ion channel family, it typically forms a pentameric complex with alpha and gamma subunits to create a chloride-selective channel (NCBI Gene: 2561). This subunit is widely distributed in the central nervous system and is crucial for maintaining the balance between neuronal excitation and inhibition (PMID: 28813301).\n\nMutations in the GABRB2 gene are clinically significant, often associated with epilepsy syndromes, febrile seizures, and psychiatric conditions like schizophrenia (PMID: 30135574). Pharmacologically, the beta-2 subunit is a critical site for the action of general anesthetics such as propofol and etomidate, which enhance GABA-mediated inhibition (PubChem: 4943). Additionally, it mediates the effects of certain anticonvulsants and sedatives, making it a focal point for developing therapies for sleep disorders and anxiety (PMID: 11160514). Understanding the specific role of GABRB2 helps in the design of subtype-selective drugs that aim to minimize side effects like excessive sedation or respiratory depression (StatPearls: NBK513311).

Other names
GABA(A) receptor subunit beta-2GABR beta-2GABA receptor beta-2 subunitGABRB2
02

Mechanism of action

Positive allosteric modulation of the GABA-A receptor complex, increasing chloride conductance and hyperpolarizing neurons (StatPearls: NBK513311).

03

Biological functions

Inhibitory neurotransmission (UniProt: P47870)Chloride ion transport (NCBI Gene: 2561)Signal transductionSynaptic transmission
04

Disease associations

Epilepsy (PMID: 28813301)Schizophrenia (PMID: 30135574)InsomniaAnxiety disordersNeurodevelopmental disorders
05

Safety considerations

SedationRespiratory depressionPotential for abuse and dependenceCognitive impairment
06

Interacting drugs

Propofol (PubChem: 4943)

5 more in the full profile.

07

Biomarkers

GABRB2 gene variants (PMID: 28813301)GABRB2 mRNA expression levels

Beyond the preview

Go deeper on Gamma-aminobutyric acid receptor subunit beta-2 (GABRB2) (GABRB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid receptor subunit beta-2 (GABRB2) (GABRB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call